Fig. 3From: Ultrasensitive bioassaying of HER-2 protein for diagnosis of breast cancer using reduced graphene oxide/chitosan as nanobiocompatible platformThe SEM images of the bare electrode (a, b and c) and rGO modified electrode (d, e and f) at different magnitudes of 200, 500 and 1000Â nmBack to article page